IL17A and pneumococcal pneumonia: These data were similar to those of IL-27-deficient mice treated with PBS control, thus highlighting that IL-27-mediated IL-17A inhibition in γδ T cells contributed to the susceptibility to secondary pneumococcal pneumonia.